151 related articles for article (PubMed ID: 1378139)
21. Comparative multicentre study of the tolerability and efficacy of epanolol versus nifedipine in patients with stable angina pectoris.
Readman AS
Drugs; 1989; 38 Suppl 2():61-5. PubMed ID: 2575983
[TBL] [Abstract][Full Text] [Related]
22. A 6-week double-blind comparison of amlodipine and placebo in patients with stable exertional angina pectoris receiving concomitant beta-blocker therapy.
Klein W; Mitrovic V; Neuss H; Schlepper M; Cocco G; Prager G; Fitscha P; Meisner W
J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S50-2. PubMed ID: 16296710
[TBL] [Abstract][Full Text] [Related]
23. Vasodilating beta-blockers in heart failure.
Raftery EB
Eur Heart J; 1995 Jul; 16 Suppl F():32-7. PubMed ID: 8521882
[TBL] [Abstract][Full Text] [Related]
24. The efficacy of the addition of nifedipine in patients with mixed angina compared to patients with classic exertional angina: a multicenter, randomized, double-blind, placebo-controlled clinical trial.
Stone PH; Ware JH; DeWood MA; Gore JM; Eich RH; Pietro DA; Parisi AF; Nesto RW; Boden WE; Sharma SC
Am Heart J; 1988 Oct; 116(4):961-71. PubMed ID: 2902779
[TBL] [Abstract][Full Text] [Related]
25. Comparison of celiprolol and propranolol in stable angina pectoris. Celiprolol International Angina Study Group.
Frishman WH; Heiman M; Soberman J; Greenberg S; Eff J
Am J Cardiol; 1991 Apr; 67(8):665-70. PubMed ID: 1672481
[TBL] [Abstract][Full Text] [Related]
26. Treatment of hypertension associated with stable angina pectoris: favourable interaction between new metoprolol formulation (OROS) and nifedipine.
Di Somma S; de Divitiis M; Bertocchi F; Carotenuto A; Cudemo G; Petitto M; Napodano M; de Divitiis O
Cardiologia; 1996 Jul; 41(7):635-43. PubMed ID: 8831181
[TBL] [Abstract][Full Text] [Related]
27. Additional antianginal and anti-ischemic efficacy of mibefradil in patients concomitantly treated with long-acting nitrates for chronic stable angina pectoris.
Frishman WH; Bittar N; Glasser S; Habib G; Smith W; Pordy R
Clin Cardiol; 1998 Jul; 21(7):483-90. PubMed ID: 9669057
[TBL] [Abstract][Full Text] [Related]
28. Carvedilol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
McTavish D; Campoli-Richards D; Sorkin EM
Drugs; 1993 Feb; 45(2):232-58. PubMed ID: 7681374
[TBL] [Abstract][Full Text] [Related]
29. Combination therapy with metoprolol and nifedipine versus monotherapy in patients with stable angina pectoris. Results of the International Multicenter Angina Exercise (IMAGE) Study.
Savonitto S; Ardissiono D; Egstrup K; Rasmussen K; Bae EA; Omland T; Schjelderup-Mathiesen PM; Marraccini P; Wahlqvist I; Merlini PA; Rehnqvist N
J Am Coll Cardiol; 1996 Feb; 27(2):311-6. PubMed ID: 8557899
[TBL] [Abstract][Full Text] [Related]
30. Anti-anginal and anti-ischemic effects of the selective beta-blocker talinolol in patients with stable angina pectoris.
Faulhaber HD; Weigmann I; Lang U; Weinsberg F; Terhaag B
Int J Clin Pharmacol Ther; 2005 Feb; 43(2):63-70. PubMed ID: 15726874
[TBL] [Abstract][Full Text] [Related]
31. Sustained-release verapamil and nifedipine in exercise-induced angina pectoris.
Foale RA; Vandenburg MJ
Eur Heart J; 1992 Feb; 13(2):256-60. PubMed ID: 1555625
[TBL] [Abstract][Full Text] [Related]
32. Antianginal efficacy of carvedilol, a new beta-blocker with vasodilating action.
Jamal SM; Freedman SB; Thomson A; Carter G; Harris PJ; Kelly DT
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S141-6. PubMed ID: 2454361
[TBL] [Abstract][Full Text] [Related]
33. Effects of nifedipine and diltiazem on myocardial ischemia in patients with severe stable angina pectoris treated with nitrates and beta-blockers.
Meluzín J; Zeman K; Stĕtka F; Simek P
J Cardiovasc Pharmacol; 1992 Dec; 20(6):864-9. PubMed ID: 1282586
[TBL] [Abstract][Full Text] [Related]
34. Antianginal and anti-ischemic efficacy of nicorandil compared with nifedipine in patients with angina pectoris and coronary heart disease: a double-blind, randomized, multicenter study.
Ulvenstam G; Diderholm E; Frithz G; Gudbrandsson T; Hedbäck B; Höglund C; Moelstad P; Perk J; Sverrisson JT
J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S67-73. PubMed ID: 1282179
[TBL] [Abstract][Full Text] [Related]
35. Effects of a new vasodilating beta-blocking drug, carvedilol, on left ventricular function in stable angina pectoris.
Lahiri A; Rodrigues EA; Al-Khawaja I; Raftery EB
Am J Cardiol; 1987 Apr; 59(8):769-74. PubMed ID: 2881480
[TBL] [Abstract][Full Text] [Related]
36. A multicenter comparison of carvedilol with hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension.
Langdon CG; Baxter GA; Young PH
J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S51-6. PubMed ID: 1721980
[TBL] [Abstract][Full Text] [Related]
37. Nifedipine gastrointestinal therapeutic system versus atenolol in stable angina pectoris. The Netherlands Working Group on Cardiovascular Research (WCN).
de Vries RJ; van den Heuvel AF; Lok DJ; Claessens RJ; Bernink PJ; Pasteuning WH; Kingma JH; Dunselman PH
Int J Cardiol; 1996 Dec; 57(2):143-50. PubMed ID: 9013266
[TBL] [Abstract][Full Text] [Related]
38. Selection of medical treatment in stable angina pectoris: results of the International Multicenter Angina Exercise (IMAGE) Study.
Ardissino D; Savonitto S; Egstrup K; Rasmussen K; Bae EA; Omland T; Schjelderup-Mathiesen PM; Marraccini P; Merlini PA; Wahlqvist I
J Am Coll Cardiol; 1995 Jun; 25(7):1516-21. PubMed ID: 7759701
[TBL] [Abstract][Full Text] [Related]
39. Carvedilol.
Frishman WH
N Engl J Med; 1998 Dec; 339(24):1759-65. PubMed ID: 9845712
[No Abstract] [Full Text] [Related]
40. Efficacy of carvedilol (BM 14,190), a new beta-blocking drug with vasodilating properties, in exercise-induced ischemia.
Kaski JC; Rodriguez-Plaza L; Brown J; Maseri A
Am J Cardiol; 1985 Jul; 56(1):35-40. PubMed ID: 2861738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
